Blood and Lymphatic Cancer-Targets and Therapy
Dove Medical Press · United Kingdom
Metrics
- Impact factor
- 3.2-1.7 Clarivate JCR
- WoS quartile
- Q2 Clarivate JCR, best category
- CAS tier
- Tier 2 Chinese Academy of Sciences
- Articles per year
- 6
- Self-citation
- 0%
About this journal
- ISSN
- 1179-9889 (print)
- Publisher
- Dove Medical Press
- Country
- United Kingdom
- Indexed in
- ESCI
- Access
- Hybrid · 96.7% gold OA
- Original research
- 33.3%
- Subject areas
- Medicine
- Categories
- Oncology
- Common topics
- Medicine, Biology, Internal Medicine, Immunology, Genetics
Similar journals
- Q2WoS
Journal of Physical Chemistry B
Impact factor 3.2h-index 363SJR 0.79 - Q2WoS
Journal of Cell Biology
Impact factor 6.1h-index 353SJR 3.27 - Q2WoS
Journal of Immunology
Impact factor 4h-index 345SJR 1.44 - Q2WoS
Langmuir
Impact factor 4.4h-index 300SJR 0.76 - Q2WoS
Human Molecular Genetics
Impact factor 3.1h-index 255SJR 1.45 - Q2WoS
Journal of Nutrition
Impact factor 4.2h-index 240SJR 1.21
Figures as of the last import; ranks are a guide, not a verdict. Back to all journals